Cargando…
Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers
PURPOSE: Immunotherapy provides a new treatment option for advanced gastric cancer (AGC). This study aims to explore the response markers of immunotherapy in AGCs. METHODS: Next-generation sequencing was performed on 44 AGC patients who received immune checkpoint inhibitors and the associations betw...
Autores principales: | Xu, Xiaoqing, Li, Jingjing, Gao, Yiding, Lv, Wangxia, Wei, Qing, Tang, Xiaowan, Hu, Jinlin, Yuan, Xing, Wu, Wei, Zhang, Lingnan, Luo, Cong, Chen, Lei, Ying, Jieer, Zhu, Xiu, Xu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916884/ https://www.ncbi.nlm.nih.gov/pubmed/35281518 http://dx.doi.org/10.1155/2022/2162229 |
Ejemplares similares
-
Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response
por: Li, Jingjing, et al.
Publicado: (2020) -
Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study
por: Wei, Qing, et al.
Publicado: (2021) -
PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
por: Wei, Qing, et al.
Publicado: (2020) -
Correlation Between Hemoglobin Levels and the Prognosis of First-Line Chemotherapy in Patients with Advanced Gastric Cancer
por: Wei, Qing, et al.
Publicado: (2020) -
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
por: Li, Song, et al.
Publicado: (2023)